Benitec Biopharma Inc.
For the period ended Jun 30, 2025. Filed Sep 22, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Sep 22, 2025
BNTC$9.04-0.6%Stored close · as of Nov 13, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Checking your notes…
During the three-month period ended June 30, 2025, none of our directors or officers adopted, modified or terminated a
“Rule 10b5-1 trading
arrangement” or
a “non-Rule
10b5-1 trading
arrangement” as such terms are defined under Item 408 of Regulation
S-K.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.